The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
IDT Australia
Melbourne, Australia
A
101-250 Employees
1975
Key takeaway
IDT Australia specializes in the high containment and high potency manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), highlighting their expertise in pharmaceutical development. With over 60 marketed drugs in their portfolio and a commitment to innovation, they are well-equipped to support drug discovery and development projects.
Highlighted product
Core business
IDT Australia | Australian Pharmaceutical Manufacturing Company
Pharmaceutical solutions at every stage A publically listed Australian cGMP pharmaceutical manufacturing company based in Melbourne. IDT Australia (Institute of Drug Technology Limited) specialises in high containment, high potency manufacture of Active Pharmaceutical Ingredients (API) and Finished Dose Forms (FDF), as well as offering a full suite of contract manufacturing services. We work closely with…
SYNthesis med chem
Melbourne, Australia
A
251-500 Employees
2007
Key takeaway
SYNthesis med chem is a global contract research organization that specializes in integrated drug discovery services, highlighting its expertise in medicinal chemistry and custom synthesis. With a diverse team of over 500 chemists across multiple locations, they offer comprehensive capabilities that enhance the drug discovery process, including innovative approaches to emerging modalities like PROTACs and ADCs.
Highlighted product
Service
SYNthesis Med Chem
ADP Consulting Pty Ltd
Melbourne, Australia
A
51-100 Employees
2011
Key takeaway
ADP Consulting is a multidisciplinary engineering and sustainability consultancy actively engaged in creating innovative solutions for the property and construction industry. Their commitment to collaboration and sustainability may be relevant for applications in the life sciences and research sectors, particularly in developing sustainable infrastructure for drug discovery initiatives.
Highlighted product
Product
ADP Consulting | Life Science + Research
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Akesa Pharma
Melbourne, Australia
A
11-50 Employees
2013
Key takeaway
The company is dedicated to advancing medicine and improving patient outcomes by providing critical support for clinical trials, which aligns with the focus on innovative drug discovery. Their commitment to delivering access to cutting-edge pharmaceuticals highlights their role in transforming healthcare through research and development.
Highlighted product
Core business
Let Discovery Live with Akesa | Clinical Trial Supply
Partner with Akesa for quality clinical trial supply and bespoke managed access programs. Let us revolutionise healthcare and improve lives.
Invion
Melbourne, Australia
A
- Employees
-
Key takeaway
Invion is at the forefront of research and development, specifically focusing on innovative technologies like Photosoft™, which could have implications for drug discovery.
Highlighted product
Core business
Discovery and Development Experts – Invion
Adjutor Healthcare
Melbourne, Australia
A
11-50 Employees
2018
Key takeaway
Adjutor Healthcare is a specialized life science consultancy that offers comprehensive development and commercialization services for medicines and medical devices, making it a valuable partner for companies involved in AI drug discovery. Their expertise in the pharmaceutical and biotechnology sectors positions them to effectively support various stages of product development.
Highlighted product
Core business
Adjutor Healthcare
A global provider of development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
AI Medical International Pty Ltd
Adelaide, Australia
A
11-50 Employees
-
Key takeaway
AIMedical is dedicated to advancing technology in research and rehabilitation, which may align with innovations in AI drug discovery. Their commitment to high-quality, cutting-edge solutions suggests a focus on enhancing performance and recovery through the latest scientific advancements.
Highlighted product
Core business
AIMedical International Pty Ltd
A dynamic young company, providing the latest Neuro-Science, Neuro-Rehab and Sport Science products to the Australian and New Zealand market
Myrio Tx
Melbourne, Australia
A
11-50 Employees
2009
Key takeaway
Myrio Therapeutics is focused on developing antibody-based therapies that target intracellular proteins, including those related to cancer and viral infections. Their advanced antibody discovery platform, Retained DisplayTM (ReD), enhances the discovery process, making it particularly relevant for innovative therapeutic developments.
Highlighted product
Core business
Homepage - Myrio Tx
AD1 Holdings Limited
Melbourne, Australia
A
11-50 Employees
2006
Key takeaway
AD1 Holdings is a technology company that focuses on creating and investing in innovative SaaS products, which may indicate a potential interest in leveraging advanced technologies like AI for drug discovery. Their emphasis on automation and optimization in software solutions suggests a commitment to enhancing processes that could be relevant in the biotech and pharmaceutical sectors.
Highlighted product
Core business
Homepage - AD1 Holdings
ai3Dsensory
Melbourne, Australia
A
1-10 Employees
-
Key takeaway
Ai3DSENSORY leverages AI to develop innovative solutions, including detailed mapping for autonomous vehicles. Their expertise in AI and sensor technologies could be relevant for advancements in AI drug discovery.
Highlighted product
Service
Ai3DSENSORY - Consultancy
Technologies which have been searched by others and may be interesting for you:
When exploring the AI drug discovery industry in Australia, several key considerations emerge. First, the regulatory landscape is crucial, with the Therapeutic Goods Administration (TGA) overseeing drug approvals and ensuring compliance with safety and efficacy standards. Understanding these regulations helps companies navigate the complex approval processes. Additionally, Australia boasts a strong research ecosystem, supported by universities and research institutions that foster innovation in AI applications for drug discovery. The competitive landscape is evolving, with both startups and established pharmaceutical companies investing in AI technologies. Collaborations between academia and industry are common, promoting knowledge-sharing and accelerating drug development timelines. Challenges such as data privacy, algorithm transparency, and the need for high-quality datasets are significant, as they can impact the effectiveness of AI models. Opportunities abound, particularly in personalized medicine and the development of novel therapeutics, which align well with global trends in healthcare innovation. Environmental considerations are also gaining traction, as companies are expected to adopt sustainable practices in their operations. Overall, the global relevance of Australia's AI drug discovery sector is significant, as advancements here can contribute to international efforts in combating diseases and improving health outcomes worldwide.
Some interesting numbers and facts about your company results for Ai Drug Discovery
| Country with most fitting companies | Australia |
| Amount of fitting manufacturers | 145 |
| Amount of suitable service providers | 148 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1975 |
| Youngest suiting company | 2018 |
Some interesting questions that has been asked about the results you have just received for Ai Drug Discovery
What are related technologies to Ai Drug Discovery?
Based on our calculations related technologies to Ai Drug Discovery are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Which industries are mostly working on Ai Drug Discovery?
The most represented industries which are working in Ai Drug Discovery are IT, Software and Services, Biotechnology, Other, Pharmaceuticals, Medical
How does ensun find these Ai Drug Discovery Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
